1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Dubovskii, P.V.
Dementieva, D.V.
Bocharov, E.V.
Utkin, Y.N.
Arseniev, A.S.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
305
137
149
10.1006/jmbi.2000.4283
11114253
Membrane binding motif of the P-type cardiotoxin.
2001
IX
Eur.J.Biochem.
EJBCAI
0262
0014-2956
263
152
162
10.1046/j.1432-1327.1999.00478.x
Two forms of Cytotoxin II (cardiotoxin) from Naja naja oxiana in Aqueous Solution. Spatial Structures with Tightly Bound Water Molecules
1999
10.2210/pdb1ffj/pdb
pdb_00001ffj
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
6648.238
CYTOTOXIN 2
1
1
nat
polymer
18.015
water
2
nat
water
CARDIOTOXIN
no
no
LKCKKLVPLFSKTCPAGKNLCYKMFMVAAPHVPVKRGCIDVCPKSSLLVKYVCCNTDKCN
LKCKKLVPLFSKTCPAGKNLCYKMFMVAAPHVPVKRGCIDVCPKSSLLVKYVCCNTDKCN
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Central Asian cobra
Naja
sample
8657
Naja oxiana
VENOM
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
2001-01-17
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
1CB9 is the Solution Structure of Cardiotoxin from Naja oxiana (major form)
RCSB
Y
RCSB
2000-07-25
REL
REL
HOH
water
This structure was determined using standard 2D homonuclear techniques. Sites of tightly bound water molecules were determined as in Dementieva et al., Eur.J.Biochem.1999,263,152-162.
target function
220
20
2D NOESY
TOCSY
DQF-COSY
ROESY
DQF-COSY
2D NOESY
TOCSY
ROESY
DQF-COSY
2D NOESY
0M NaCl
5.5
ambient
318
K
0M NaCl
5.5
ambient
303
K
structures are based on a total of 368 NOE-derived constraints, 154 dihedral angle restraints, 248 distance restraints from hydrogen bonds and disulfides
torsion angle dynamics
1
fewest violations
3mM Cardiotoxin (cytotoxin II); 120 mM perdeuterated dodecylphosphocholine
90% H2O/10% D2O
3mM Cardiotoxin (cytotoxin II); 120 mM perdeuterated dodecylphosphocholine
100% D2O
Varian software
collection
VNMR
6.1A
Xia, T. & Bartels, C.
data analysis
XEASY
1.2.11
Guentert, P. & Mumenthaler, C.
structure solution
DYANA
1.5
Guentert, P. & Mumenthaler, C.
refinement
DYANA
1.5
600
Varian
UNITY
HOH
61
2
HOH
HOH
61
A
HOH
62
2
HOH
HOH
62
A
LEU
1
n
1
LEU
1
A
LYS
2
n
2
LYS
2
A
CYS
3
n
3
CYS
3
A
LYS
4
n
4
LYS
4
A
LYS
5
n
5
LYS
5
A
LEU
6
n
6
LEU
6
A
VAL
7
n
7
VAL
7
A
PRO
8
n
8
PRO
8
A
LEU
9
n
9
LEU
9
A
PHE
10
n
10
PHE
10
A
SER
11
n
11
SER
11
A
LYS
12
n
12
LYS
12
A
THR
13
n
13
THR
13
A
CYS
14
n
14
CYS
14
A
PRO
15
n
15
PRO
15
A
ALA
16
n
16
ALA
16
A
GLY
17
n
17
GLY
17
A
LYS
18
n
18
LYS
18
A
ASN
19
n
19
ASN
19
A
LEU
20
n
20
LEU
20
A
CYS
21
n
21
CYS
21
A
TYR
22
n
22
TYR
22
A
LYS
23
n
23
LYS
23
A
MET
24
n
24
MET
24
A
PHE
25
n
25
PHE
25
A
MET
26
n
26
MET
26
A
VAL
27
n
27
VAL
27
A
ALA
28
n
28
ALA
28
A
ALA
29
n
29
ALA
29
A
PRO
30
n
30
PRO
30
A
HIS
31
n
31
HIS
31
A
VAL
32
n
32
VAL
32
A
PRO
33
n
33
PRO
33
A
VAL
34
n
34
VAL
34
A
LYS
35
n
35
LYS
35
A
ARG
36
n
36
ARG
36
A
GLY
37
n
37
GLY
37
A
CYS
38
n
38
CYS
38
A
ILE
39
n
39
ILE
39
A
ASP
40
n
40
ASP
40
A
VAL
41
n
41
VAL
41
A
CYS
42
n
42
CYS
42
A
PRO
43
n
43
PRO
43
A
LYS
44
n
44
LYS
44
A
SER
45
n
45
SER
45
A
SER
46
n
46
SER
46
A
LEU
47
n
47
LEU
47
A
LEU
48
n
48
LEU
48
A
VAL
49
n
49
VAL
49
A
LYS
50
n
50
LYS
50
A
TYR
51
n
51
TYR
51
A
VAL
52
n
52
VAL
52
A
CYS
53
n
53
CYS
53
A
CYS
54
n
54
CYS
54
A
ASN
55
n
55
ASN
55
A
THR
56
n
56
THR
56
A
ASP
57
n
57
ASP
57
A
LYS
58
n
58
LYS
58
A
CYS
59
n
59
CYS
59
A
ASN
60
n
60
ASN
60
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
CYS
3
A
O
CYS
3
A
N
LYS
12
A
N
LYS
12
A
N
ILE
39
A
N
ILE
39
A
O
LEU
20
A
O
LEU
20
A
O
PHE
25
A
O
PHE
25
A
N
LYS
50
A
N
LYS
50
1
A
A
H
O
MET
HOH
26
61
1.52
2
A
A
H
O
MET
HOH
26
61
1.25
2
A
A
HG
O
SER
VAL
46
49
1.58
4
A
A
H
O
MET
HOH
26
61
1.39
5
A
A
H
O
MET
HOH
26
61
1.45
6
A
A
H
O
MET
HOH
26
61
1.41
7
A
A
H
O
MET
HOH
26
61
1.59
8
A
A
H
O
MET
HOH
26
61
1.50
9
A
A
HG
O
SER
VAL
46
49
1.54
10
A
A
H
O
MET
HOH
26
61
1.55
11
A
A
H
O
MET
HOH
26
61
1.40
12
A
A
O
H1
MET
HOH
26
61
1.52
12
A
A
O
O
MET
HOH
26
61
2.02
14
A
A
H
O
MET
HOH
26
61
1.32
16
A
A
H
O
MET
HOH
26
61
1.23
16
A
A
HG
O
SER
VAL
46
49
1.58
17
A
A
H
O
MET
HOH
26
61
1.19
17
A
A
N
O
MET
HOH
26
61
2.17
18
A
A
H
O
MET
HOH
26
61
1.45
19
A
A
H
O
MET
HOH
26
61
1.21
19
A
A
HZ2
HD2
LYS
ASP
18
40
1.27
20
A
A
H
O
MET
HOH
26
61
1.24
20
A
A
N
O
MET
HOH
26
61
2.17
1
A
VAL
32
-155.90
87.22
1
A
ASN
55
-105.26
63.75
2
A
ALA
28
-37.03
-38.49
2
A
VAL
32
-157.11
78.58
2
A
ASN
55
-108.13
70.35
3
A
LEU
6
-40.69
-71.70
3
A
VAL
32
-157.41
78.46
3
A
ASN
55
-107.53
63.61
4
A
VAL
32
-153.07
84.04
4
A
ASN
55
-113.87
70.59
5
A
ALA
16
-40.18
155.02
5
A
ALA
28
-37.14
-39.17
5
A
VAL
32
-158.75
84.94
5
A
ASN
55
-118.81
63.38
6
A
LEU
6
-42.81
-70.23
6
A
ALA
16
-48.35
156.07
6
A
VAL
32
-152.21
85.45
7
A
VAL
32
-156.59
74.41
7
A
ASN
55
-103.27
69.03
8
A
LEU
6
-39.77
-73.30
8
A
ALA
16
-42.30
157.77
8
A
VAL
32
-158.35
81.26
9
A
ALA
16
-40.31
157.36
9
A
HIS
31
-142.21
57.54
9
A
ASN
55
-109.77
65.90
10
A
LEU
6
-40.75
-72.13
10
A
VAL
32
-151.68
87.29
10
A
ASN
55
-110.81
66.10
11
A
ALA
16
-44.69
158.74
11
A
VAL
32
-155.12
83.94
12
A
LYS
5
-75.59
-167.04
12
A
VAL
32
-156.59
80.75
12
A
CYS
54
-171.41
143.27
12
A
ASN
55
-103.61
62.12
13
A
ALA
16
-43.49
163.41
13
A
ASN
55
-110.87
66.27
14
A
VAL
32
-157.54
84.02
15
A
HIS
31
-140.28
48.19
15
A
ASN
55
-112.65
66.34
16
A
ALA
16
-40.01
158.07
16
A
ASN
55
-105.70
69.38
17
A
ALA
16
-41.10
151.80
17
A
ASN
55
-108.18
60.88
18
A
LEU
6
-42.25
-73.32
18
A
ALA
16
-43.78
156.09
18
A
VAL
32
-156.95
85.31
18
A
CYS
54
-170.62
139.03
18
A
ASN
55
-101.73
58.01
19
A
ALA
16
-45.88
151.21
19
A
ALA
28
-36.90
-36.95
19
A
VAL
32
-151.75
88.43
19
A
ASN
55
-104.19
64.45
20
A
ALA
16
-42.49
150.88
20
A
HIS
31
-142.61
54.54
20
A
VAL
32
-152.70
87.83
20
A
CYS
54
-170.37
144.61
20
A
ASN
55
-105.74
58.54
NMR STRUCTURE OF CARDIOTOXIN IN DPC-MICELLE
1
N
N
2
N
N
disulf
2.034
A
CYS
3
A
SG
CYS
3
1_555
A
CYS
21
A
SG
CYS
21
1_555
disulf
1.979
A
CYS
14
A
SG
CYS
14
1_555
A
CYS
38
A
SG
CYS
38
1_555
disulf
2.080
A
CYS
42
A
SG
CYS
42
1_555
A
CYS
53
A
SG
CYS
53
1_555
disulf
2.088
A
CYS
54
A
SG
CYS
54
1_555
A
CYS
59
A
SG
CYS
59
1_555
TOXIN
all-beta sheet protein, membrane perturbation, TOXIN
CX2_NAJOX
UNP
1
1
P01441
LKCKKLVPLFSKTCPAGKNLCYKMFMVAAPHVPVKRGCIDVCPKSSLLVKYVCCNTDKCN
1
60
1FFJ
1
60
P01441
A
1
1
60
2
3
anti-parallel
anti-parallel
anti-parallel
A
LYS
2
A
LYS
2
A
LYS
4
A
LYS
4
A
SER
11
A
SER
11
A
THR
13
A
THR
13
A
PRO
33
A
PRO
33
A
ILE
39
A
ILE
39
A
LEU
20
A
LEU
20
A
MET
26
A
MET
26
A
VAL
49
A
VAL
49
A
CYS
54
A
CYS
54
1
P 1